Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in Colombia
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The primary goal of this study is to quantify the benefit of adding artesunate to amodiaquine
in treating patients with uncomplicated P. falciparum malaria, in a low transmission area in
Colombia. The benefit will be assessed in terms of:
- Efficacy
- Tolerability
- Time of fever clearance
- Time of parasite clearance
- Proportion of gametocyte carriers
Phase:
Phase 3
Details
Lead Sponsor:
Centro Internacional de Entrenamiento e Investigaciones Médicas
Collaborators:
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) World Health Organization